PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer.

Saved in:
Bibliographic Details
Title: PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer.
Authors: Dosset M; INSERM, U1231, Dijon, France.; INSERM, U1098, Besançon, France.; LabEx LipSTIC, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France., Vargas TR; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Lagrange A; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Boidot R; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France., Végran F; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France., Roussey A; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Chalmin F; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Dondaine L; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Paul C; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Lauret Marie-Joseph E; INSERM, U1098, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France., Martin F; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France., Ryffel B; University of Cape Town, RSA, CNRS, UMR7355, Orleans, France, IDM., Borg C; INSERM, U1098, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Department of Medical Oncology, University Hospital of Besançon, France., Adotévi O; INSERM, U1098, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Department of Medical Oncology, University Hospital of Besançon, France., Ghiringhelli F; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France., Apetoh L; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France.
Source: Oncoimmunology [Oncoimmunology] 2018 Mar 15; Vol. 7 (6), pp. e1433981. Date of Electronic Publication: 2018 Mar 15 (Print Publication: 2018).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29872568
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dosset+M%22">Dosset M</searchLink>; INSERM, U1231, Dijon, France.; INSERM, U1098, Besançon, France.; LabEx LipSTIC, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Vargas+TR%22">Vargas TR</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Lagrange+A%22">Lagrange A</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Boidot+R%22">Boidot R</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Végran+F%22">Végran F</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Roussey+A%22">Roussey A</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Chalmin+F%22">Chalmin F</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Dondaine+L%22">Dondaine L</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Paul+C%22">Paul C</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Lauret+Marie-Joseph+E%22">Lauret Marie-Joseph E</searchLink>; INSERM, U1098, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Martin+F%22">Martin F</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Ryffel+B%22">Ryffel B</searchLink>; University of Cape Town, RSA, CNRS, UMR7355, Orleans, France, IDM.<br /><searchLink fieldCode="AU" term="%22Borg+C%22">Borg C</searchLink>; INSERM, U1098, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Department of Medical Oncology, University Hospital of Besançon, France.<br /><searchLink fieldCode="AU" term="%22Adotévi+O%22">Adotévi O</searchLink>; INSERM, U1098, Besançon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Department of Medical Oncology, University Hospital of Besançon, France.<br /><searchLink fieldCode="AU" term="%22Ghiringhelli+F%22">Ghiringhelli F</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Apetoh+L%22">Apetoh L</searchLink>; INSERM, U1231, Dijon, France.; Université de Bourgogne Franche Comté, Dijon, France.; Centre Georges François Leclerc, Dijon, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2018 Mar 15; Vol. 7 (6), pp. e1433981. <i>Date of Electronic Publication: </i>2018 Mar 15 (<i>Print Publication: </i>2018).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-4011 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29872568
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2018.1433981
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1433981
    Titles:
      – TitleFull: PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dosset M
      – PersonEntity:
          Name:
            NameFull: Vargas TR
      – PersonEntity:
          Name:
            NameFull: Lagrange A
      – PersonEntity:
          Name:
            NameFull: Boidot R
      – PersonEntity:
          Name:
            NameFull: Végran F
      – PersonEntity:
          Name:
            NameFull: Roussey A
      – PersonEntity:
          Name:
            NameFull: Chalmin F
      – PersonEntity:
          Name:
            NameFull: Dondaine L
      – PersonEntity:
          Name:
            NameFull: Paul C
      – PersonEntity:
          Name:
            NameFull: Lauret Marie-Joseph E
      – PersonEntity:
          Name:
            NameFull: Martin F
      – PersonEntity:
          Name:
            NameFull: Ryffel B
      – PersonEntity:
          Name:
            NameFull: Borg C
      – PersonEntity:
          Name:
            NameFull: Adotévi O
      – PersonEntity:
          Name:
            NameFull: Ghiringhelli F
      – PersonEntity:
          Name:
            NameFull: Apetoh L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 03
              Text: 2018 Mar 15
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 2162-4011
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1